(855) 924-532024/7 Admissions

Relapse: Signs, Causes, Effects and Prevention Techniques

11 min read

Published ·Updated

Relapse: Signs, Causes, Effects and Prevention Techniques

Relapse is the return to substance use after a period of abstinence, and in a chronic condition it is a recorded clinical event rather than proof that treatment failed. The National Institute on Drug Abuse puts the relapse rate for substance use disorders at 40 to 60 percent, alongside 50 to 70 percent for hypertension and 50 to 70 percent for asthma.

Relapse is also a sequence with a measurable shape. Melemis, Steven M. set that sequence out in his 2015 paper Relapse Prevention and the Five Rules of Recovery in the Yale Journal of Biology and Medicine as three stages, emotional, mental and physical, in which the return to use is the final step rather than the first one. The interval between the first stage and the last is where prevention work happens.

What Is A Relapse?

A relapse is a return to uncontrolled substance use after abstinence, and a lapse is the initial drink or drug use. Melemis reports that some researchers divide physical relapse this way, and notes that one use may quickly lead to uncontrolled use. The distinction still decides what happens next: a lapse triggers a review of the plan, and a relapse triggers a reassessment of the level of care.

Both terms describe behavior rather than character, and the language a clinical record uses carries consequences for the person in it. Relapse belongs to the natural history of substance use disorder in the same way that a rise in blood pressure belongs to the natural history of hypertension. The condition is chronic, the treatment is episodic, and the gap between those two facts is what produces a return to use. How wide that gap runs in practice is measurable.

How Common Is Relapse After Addiction Treatment?

Relapse affects 40 to 60 percent of people treated for a substance use disorder, a figure the National Institute on Drug Abuse publishes specifically to be compared with other chronic illnesses. Those comparisons are close enough that the difference in how each condition is judged looks like a matter of stigma rather than medicine.

The 3 conditions below are the comparison NIDA draws, and the rates are the ones it publishes for each.

ConditionRate of return to symptoms after treatmentHow a return is treated clinically
Substance use disorder40 to 60 percentReassessment of the treatment plan and the level of care
Hypertension50 to 70 percentAdjustment of medication and behavioral plan
Asthma50 to 70 percentAdjustment of controller therapy and trigger management
Rates of return to symptoms after treatment for substance use disorder, hypertension and asthma, as published by the National Institute on Drug Abuse.

Timescale matters as much as rate. Dennis, Michael and Scott, Christy K. reported in their 2007 paper "Managing addiction as a chronic condition" in Addiction Science and Clinical Practice that in a longitudinal cohort of 1,271 patients, the median time from first substance use to at least one drug-free year was 27 years, and the median time from a first treatment episode to a first alcohol-free and drug-free year was 9 years, across three to four episodes of different kinds of treatment. In the same work, the odds of moving from use to recovery rose by a factor of 1.14 for every 9 weeks of treatment received during a year. Those numbers describe a long arc with repeated re-entry inside it, which is the shape a single relapse sits within.

What Are The Stages Of Relapse?

Relapse runs through 3 stages in fixed order: emotional relapse, in which self-care erodes before any thought of using appears; mental relapse, in which craving argues with commitment; and physical relapse, the return to use itself. Melemis identifies poor self-care as the common feature of the first stage.

Emotional relapse shows up as bottled-up emotion, isolation, skipped meetings and neglected physical health, with no intention to use present. Mental relapse opens an internal argument: part of the person wants to use and part does not, and the signs are craving, thinking about the people and places attached to past use, minimizing consequences, bargaining and planning. Physical relapse is the act of using, and Melemis observes that physical relapses are largely relapses of opportunity. Each stage carries its own warning signs and its own matched response, set out in full with the research behind them in the guide to the 3 stages of relapse.

What Are The Early Warning Signs Of Relapse?

The early warning signs are 5 observable changes: withdrawal from support, abandoned self-care, a shift toward minimizing past consequences, returning contact with the people and places attached to use, and rising craving that is no longer being reported to anyone. Each appears before physical relapse rather than after it.

The 5 signs below map onto the emotional and mental stages, and each is visible to a person's clinician, family or peers before it is acted on.

  • Withdrawal from support, including cancelled therapy appointments, missed peer meetings and avoided contact with family.
  • Abandoned self-care, including disrupted sleep, skipped meals, stopped exercise and neglected hygiene.
  • Minimizing past consequences, including retelling the history of use with the harm edited out of it.
  • Returning contact with cues, including renewed contact with people, places and routines attached to past use.
  • Unreported craving, including craving that a person stops disclosing to a clinician or sponsor.
Relapse prevention guide covering support networks, self-care, trigger recognition and regular therapy sessions

The full behavioral, cognitive and physical inventory is set out in the guide to relapse warning signs. Signs describe what a relapse looks like from outside; the mechanisms driving it sit underneath.

What Causes A Relapse?

Relapse is driven by 4 recurring mechanisms: stress, conditioned environmental cues, untreated psychiatric conditions, and the withdrawal of clinical contact or medication before the plan called for it. Each acts on the same reward and stress circuitry that the substance itself acted on.

Sinha, Rajita reviewed the stress mechanism in her 2008 paper "Chronic Stress, Drug Use, and Vulnerability to Addiction" in the Annals of the New York Academy of Sciences. In laboratory work with people who used cocaine, stress-induced craving predicted time to relapse. In people with alcohol dependence, negative mood, stress-induced alcohol craving and blunted stress-induced and cue-induced cortisol responses were associated with relapse outcomes. In nicotine-deprived smokers exposed to a series of stressors, blunted ACTH, cortisol and blood-pressure responses appeared alongside increased withdrawal and craving scores, and those responses predicted nicotine relapse. The pattern that repeats across all three substances is heightened craving paired with impaired stress regulation.

The 4 mechanisms below account for the recorded pathways back to use.

  1. Stress raises craving and degrades the regulatory response that would otherwise contain it.
  2. Conditioned cues reinstate craving through people, places, objects and routines paired with past use.
  3. Untreated psychiatric conditions return a person to the substance as a means of managing symptoms that nothing else is managing.
  4. Withdrawn treatment contact removes the monitoring and medication that were holding the plan in place.

One consequence of a return to use is more dangerous than the rest, and it arrives in the first hours.

Why Does Overdose Risk Rise After A Relapse?

Tolerance falls during abstinence. A dose a person tolerated before treatment can cause fatal respiratory depression when use resumes at the same amount, which makes the hours immediately after a return to use the highest-risk window for fatal overdose in the whole course of the disorder. The risk is highest for opioids.

Call 911 immediately for any suspected overdose. Call Poison Help at 1-800-222-1222 for any ingestion or overdose. The over-the-counter NARCAN label directs a bystander to give a dose for a suspected overdose and to stay until the ambulance arrives even if the person wakes up, because naloxone wears off faster than the opioids it reverses. Naloxone access, dosing and administration are covered in the guide to naloxone.

The size of the risk has been measured directly in a population that experiences forced abstinence followed by sudden availability. Binswanger, Ingrid A. and colleagues reported in their 2007 study Release from prison, a high risk of death for former inmates in the New England Journal of Medicine that in the first two weeks after release, the risk of death was 12.7 times that of other state residents, and the risk of death from drug overdose was 129 times that of other state residents. The mechanism is the same one that operates after any period of abstinence: tolerance falls, the remembered dose does not, and the margin between them disappears. That is the specific harm relapse prevention exists to remove.

Which Relapse-Prevention Methods Have Evidence Behind Them?

The methods with randomized-trial evidence cited here are structured relapse prevention and mindfulness-based relapse prevention. Each targets a different part of the sequence, from the erosion of self-care through to the reinstatement of craving.

Bowen, Sarah and colleagues tested the first two directly in their 2014 randomized clinical trial in JAMA Psychiatry. They assigned 286 people who had completed inpatient or intensive outpatient treatment to an 8-week aftercare program of mindfulness-based relapse prevention, standard relapse prevention or treatment as usual. At 6 months, both mindfulness-based and standard relapse prevention produced a significantly lower risk of relapse to substance use and heavy drinking than treatment as usual. At 12 months, the mindfulness-based arm reported significantly fewer days of substance use and significantly less heavy drinking than either comparison.

Relapse prevention strategies covering therapy and support groups, trigger management, support networks, lifestyle habits and medication

The 5 actions below convert those findings into a plan a person can hold.

  • Name the specific triggers in writing, listing the people, places, times and emotional states that preceded past use.
  • Schedule the clinical contact rather than leaving it to be arranged after a bad week.
  • Continue prescribed medication for opioid or alcohol use disorder for the duration the prescriber set, not the duration that feels sufficient.
  • Protect sleep, food and movement, since erosion of those three is the observable start of emotional relapse.
  • Tell one person early, because craving that goes unreported is the one warning sign a clinician cannot act on.

A plan written before a bad week is worth more than a decision taken during one, which is also true of the hours immediately after a relapse has already happened.

What Are The First Steps After A Relapse Happens?

The first 24 hours call for 5 actions in order: get medically assessed if the amount used carried overdose risk, tell the treating clinician, restart the treatment plan at whatever level of care the reassessment supports, remove the remaining supply, and return to the peer support that was already in place.

The 5 steps below run in sequence, and each one produces information the next step depends on.

  1. Get a medical assessment the same day when the amount used, the substance or the length of abstinence created overdose risk.
  2. Contact the treating clinician and report the amount, the substance and the interval since the last use.
  3. Reenter treatment at the level of care the reassessment supports, which is decided by current risk rather than by prior treatment history.
  4. Remove the remaining supply and the immediate access route to more of it.
  5. Return to peer support within the same week rather than waiting for a clean stretch first.

Reentry is a clinical step rather than a restart from zero, and the level of care it produces comes from the same continuum any first admission runs on. The full continuum, from remission monitoring through to medically managed inpatient care, is set out in the guide to addiction treatment, and what happens across the months that follow is covered in the guide to recovery from addiction.

What Are The Most Common Questions About Relapse?

The 6 questions below cover whether relapse means treatment failed, when relapse is most likely, whether progress is lost, medication, family response, and how relapse differs across substances.

Does A Relapse Mean Treatment Failed?

No. NIDA frames a return to use in substance use disorder the way clinicians frame a return of symptoms in hypertension or asthma: as a signal to adjust the treatment plan. The failure would be leaving the plan unadjusted.

When Is Relapse Most Likely To Happen?

The highest-risk window follows any break in treatment contact, and the highest-risk window for fatal overdose follows any extended period of abstinence, because tolerance falls while the remembered dose does not.

Does A Relapse Erase The Progress Already Made?

No. Dennis and Scott recorded sustained recovery arriving across three to four episodes of treatment rather than one, and measured rising odds of moving from use to recovery with every additional 9 weeks of treatment received.

Do Medications Reduce Relapse Risk?

Yes, for opioid and alcohol use disorder. Buprenorphine, methadone and naltrexone are approved for opioid use disorder, and naltrexone, acamprosate and disulfiram for alcohol use disorder. Stopping them without a prescriber's plan restores the risk they were reducing.

How Can Family Respond To A Relapse?

Treat overdose risk first, then reporting. Call 911 for any suspected overdose and Poison Help at 1-800-222-1222 for any ingestion. Once the person is safe, the useful action is contacting the treating clinician rather than negotiating alone.

Does Relapse Look The Same For Every Substance?

The three-stage sequence holds across substances. The consequences do not. Opioid relapse after abstinence carries the highest immediate mortality risk, because respiratory depression follows a dose that was survivable before tolerance fell.

Sources & References7Show
  1. NIDA. Drugs, Brains, and Behavior: The Science of Addiction, Treatment and RecoverySource of the 40 to 60 percent relapse rate for substance use disorders and the 50 to 70 percent comparison rates for hypertension and asthma.
  2. Melemis SM. Relapse Prevention and the Five Rules of Recovery. Yale Journal of Biology and Medicine, 2015;88(3):325-332Source of the three stages of relapse, the description of poor self-care as the common feature of emotional relapse, the report that some researchers divide physical relapse into a lapse and a relapse, and the observation that physical relapses are largely relapses of opportunity.
  3. Dennis M, Scott CK. Managing addiction as a chronic condition. Addiction Science and Clinical Practice, 2007;4(1):45-55Source of the 27-year median from first use to a first drug-free year, the 9-year median from first treatment, the three to four treatment episodes, the cohort of 1,271 patients, and the 1.14 odds ratio per 9 weeks of treatment received.
  4. Binswanger IA, Stern MF, Deyo RA, et al. Release from prison, a high risk of death for former inmates. New England Journal of Medicine, 2007;356(2):157-165Source of the relative risk of death of 12.7 in the first two weeks after release and the relative risk of death from drug overdose of 129, both against other state residents.
  5. Sinha R. Chronic Stress, Drug Use, and Vulnerability to Addiction. Annals of the New York Academy of Sciences, 2008;1141:105-130Source of the stress mechanism findings: stress-induced cocaine craving predicting time to relapse, the alcohol findings on negative mood and blunted cortisol response, and the nicotine findings on blunted ACTH and cortisol alongside increased craving.
  6. Bowen S, Witkiewitz K, Clifasefi SL, et al. Relative efficacy of mindfulness-based relapse prevention, standard relapse prevention, and treatment as usual for substance use disorders: a randomized clinical trial. JAMA Psychiatry, 2014;71(5):547-556Source of the 286-participant aftercare trial, the 6-month result for both prevention arms against treatment as usual, and the 12-month advantage of the mindfulness-based arm.
  7. NIDA. Naloxone DrugFactsReference for naloxone as the opioid overdose reversal medication named in the emergency guidance on this page.

Get Help for Addiction Today

Valley Spring Recovery Center, CARF accredited, NJ licensed, in-network with 19 payers.

HIPAA compliant · Confidential · No obligation